Purchases and Sales Made in Q2 2021 in Seelos Therapeutics, Inc. (SEEL)
This table provides information about the institutional ownership of Seelos Therapeutics, Inc. (SEEL) during Q2 2021. The information is specifically focused on institutions that hold shares of SEELOS THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2021
Q2 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-609KClosed |
$1.61M - $3.85M
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-612KClosed |
$1.61M - $3.87M
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Mangrove Partners
New York, NY |
SELL
|
- |
-2.16MClosed |
$5.71M - $13.7M
|
0
$0
|
|
|
Aug 17, 2021
Q2 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-3.44M- 99.41% |
$9.09M - $21.8M
|
20.3K
$7.92K
|